---
title: Preliminary experience of surgery after neoadjuvant immunotherapy combined
  with chemotherapy for stage-IIIB non-small cell lung cancer
date: '2024-08-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39144346/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240815181506&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Neoadjuvant immunotherapy and chemotherapy combined with
  surgery in patients with stage-IIIB NSCLC is safe and feasible. The patient outcomes
  and optimal number of neoadjuvant treatment cycles need to be explored and studied
  ...'
disable_comments: true
---
CONCLUSIONS: Neoadjuvant immunotherapy and chemotherapy combined with surgery in patients with stage-IIIB NSCLC is safe and feasible. The patient outcomes and optimal number of neoadjuvant treatment cycles need to be explored and studied ...